| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SIENTRA INC | 2,199,012 | 19,769,000 | 18.95% | ||
| 2 | Proteon Therapeutics | 2,017,872 | 18,383,000 | 17.62% | ||
| 3 | PARATEK PHARMACEUTICALS INC | 1,301,413 | 16,918,000 | 16.22% | ||
| 4 | CEMPRA INC | 383,935 | 9,287,000 | 8.90% | ||
| 5 | CHIASMA INC | 2,080,595 | 6,096,000 | 5.84% | ||
| 6 | Dicerna Pharmaceuticals | 945,757 | 5,561,000 | 5.33% | ||
| 7 | NOVAN INC COM | 200,000 | 4,032,000 | 3.86% | ||
| 8 | Innocoll | 555,555 | 3,228,000 | 3.09% | ||
| 9 | LOMBARD MEDICAL INC | 3,473,452 | 3,201,000 | 3.07% | ||
| 10 | CymaBay Therapeutics | 1,600,000 | 3,104,000 | 2.98% | ||
| 11 | CELLECTIS S A | 100,000 | 2,407,000 | 2.31% | ||
| 12 | DERMIRA INC | 70,000 | 2,367,000 | 2.27% | ||
| 13 | SENSEONICS HOLDINGS INC | 516,882 | 2,000,000 | 1.92% | ||
| 14 | ADAPTIMMUNE THERAPEUTICS PLC | 250,000 | 1,763,000 | 1.69% | ||
| 15 | ANTHERA PHARMACEUTICALS I | 512,036 | 1,531,000 | 1.47% | ||
| 16 | IMMUNE DESIGN CORP COM | 197,300 | 1,494,000 | 1.43% | ||
| 17 | AURINIA PHARMACEUTICALS INC | 437,994 | 1,375,000 | 1.32% | ||
| 18 | REGULUS THERAPEUTICS INC | 327,350 | 1,080,000 | 1.04% | ||
| 19 | HISTOGENICS CORP | 176,904 | 543,000 | 0.52% | ||
| 20 | OncoGenex Pharmaceuticals Inc | 396,104 | 195,000 | 0.19% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-021952, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
